Opportunity

DIBBS #SPE2DP-26-T-4854

Procurement of Atenolol Tablets, 25 mg, 100 Count Bottles for DLA Medical Supply Chain

Posted

September 02, 2026

Respond By

September 08, 2026

Identifier

SPE2DP-26-T-4854

NAICS

424210

This opportunity is issued by the Defense Logistics Agency Troop Support Medical Supply Chain Pharmacy FSA for the procurement of Atenolol Tablets. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - OEMs and Vendors: - McKesson Corporation (P/N 463649) - Teva Pharmaceuticals USA, Inc. (P/N NDC00093-0787-01) - Mylan Pharmaceuticals Inc. (P/N NDC00378-0218-01) - Products Requested: - Atenolol Tablets, 25 mg, 100 count bottles - NSN 6505-01-336-6196 - Total quantity: 10 bottles (5 under CLIN 0001, 5 under CLIN 0002) - Notable Requirements: - Delivery required within 5 days from order date (FOB destination) - FDA regulated product - Packaging and marking must comply with DLA requirements - Shelf life: 36 months, non-extendable - Only approved manufacturers listed above are acceptable - No additional technical attachments or unique requirements beyond standard regulatory and packaging specifications.

Description

ATENOLOL TABLETS (QTY: 5, NSN: 6505-01-336-6196, Purchase Request: 7018153084) Approved Sources: - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.

ATENOLOL TABLETS (QTY: 5, NSN: 6505-01-336-6196, Purchase Request: 7018131205) Approved Sources: - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.

View original listing